Abstract
Human pluripotent stem cell-derived neural progenitor (hNP) cells are an excellent resource for understanding early neural development and neurodegenerative disorders. Given that many neurodegenerative disorders can be correlated with defects in the mitochondrial genome, optimal utilization of hNP cells requires an ability to manipulate and monitor changes in the mitochondria. Here, we describe a novel approach that uses recombinant human mitochondrial transcription factor A (rhTFAM) protein to transfect and express a pathogenic mitochondrial genome (mtDNA) carrying the G11778A mutation associated with Leber's hereditary optic neuropathy (LHON) disease, into dideoxycytidine (ddC)-treated hNPs. Treatment with ddC reduced endogenous mtDNA and gene expression, without loss of hNP phenotypic markers. Entry of G11778A mtDNA complexed with the rhTFAM was observed in mitochondria of ddC-hNPs. Expression of the pathogenic RNA was confirmed by restriction enzyme analysis of the SfaN1-digested cDNA. On the basis of the expression of neuron-specific class III beta-tubulin, neuronal differentiation occurred. Our results show for the first time that pathogenic mtDNA can be introduced and expressed into hNPs without loss of phenotype or neuronal differentiation potential. This mitochondrial gene replacement technology allows for creation of in vitro stem cell-based models useful for understanding neuronal development and treatment of neurodegenerative disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Iyer S, Alsayegh K, Abraham S, Rao RR . Stem cell-based models and therapies for neurodegenerative diseases. Crit Rev Biomed Eng 2009; 37: 321–353.
Wallace DC, Singh G, Lott MY, Hodge JA, Schurr TG, Lezza AM et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988; 242: 1427–1430.
Yen MY, Wang AG, Wei YH . Leber's hereditary optic neuropathy: a multifactorial disease. Prog Retin Eye Res 2006; 25: 381–396.
DiMauro S, Schon EA . Mitochondrial disorders in the nervous system. Annu Rev Neurosci 2008; 31: 91–123.
Wallace DC . A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005; 39: 359–407.
Debray FG, Lambert M, Mitchell GA . Disorders of mitochondrial function. Curr Opin Pediatr 2008; 20: 471–482.
Borland MK, Mohanakumar KP, Rubinstein JD, Keeney PM, Xie J, Capaldi R et al. Relationships among molecular genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissues. Biochim Biophys Acta 2009; 1792: 68–74.
Ghosh SS, Swerdlow RH, Miller SW, Sheeman B, Parker WD, Davis RE . Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease. Ann NY Acad Sci 1999; 893: 176–191.
Trimmer PA, Bennett Jr JP . The cybrid model of sporadic Parkinson's disease. Exp Neurol 2009; 218: 320–325.
Dhara SK, Hasneen K, Machacek DW, Boyd NL, Rao RR, Stice SL . Human neural progenitor cells derived from embryonic stem cells in feeder-free cultures. Differentiation 2008; 76: 454–464.
Dhara SK, Stice SL . Neural differentiation of human embryonic stem cells. J Cell Biochem 2008; 105: 633–640.
Shin S et al. Long-term proliferation of human embryonic stem cell-derived neuroepithelial cells using defined adherent culture conditions. Stem Cells 2006; 24: 125–138.
Young A, Assey KS, Sturkie CD, West FD, Machacek DW, Stice SL . Glial cell line-derived neurotrophic factor enhances in vitro differentiation of mid-/hindbrain neural progenitor cells to dopaminergic-like neurons. J Neurosci Res 2010; 88: 3222–3232.
Dhara SK, Gerwe BA, Majumder A, Dodla MC, Boyd NL, Machacek DW et al. Genetic manipulation of neural progenitors derived from human embryonic stem cells. Tissue Eng Part A 2009; 15: 3621–3634.
Wilson PG, Cherry JJ, Schwamberger S, Adams AM, Zhou J, Shin S et al. An SMA project report: neural cell-based assays derived from human embryonic stem cells. Stem Cells Dev 2007; 16: 1027–1041.
Jin K, Mao X, Xie L, Galvan V, Lai B, Wang Y et al. Transplantation of human neural precursor cells in matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats. J Cereb Blood Flow Metab 2010; 30: 534–544.
Kang D, Kim SH, Hamasaki N . Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. Mitochondrion 2007; 7: 39–44.
Scarpulla RC . Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 2008; 88: 611–638.
Wallace DC . Animal models for mitochondrial disease. Methods Mol Biol 2002; 197: 3–54.
Iyer S, Thomas RR, Portell FR, Dunham LD, Quigley CK, Bennett JP . Recombinant mitochondrial transcription factor A with N-terminal mitochondrial transduction domain increases respiration and mitochondrial gene expression. Mitochondrion 2009; 9: 196–203.
Bonawitz ND, Clayton DA, Shadel GS . Initiation and beyond: multiple functions of the human mitochondrial transcription machinery. Mol Cell 2006; 24: 813–825.
Brown TA, Clayton DA . Release of replication termination controls mitochondrial DNA copy number after depletion with 2′,3′-dideoxycytidine. Nucleic Acids Res 2002; 30: 2004–2010.
Keeney PM, Quigley CK, Dunham LD, Papageorge CM, Iyer S, Thomas RR et al. Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model. Hum Gene Ther 2009; 20: 897–907.
Kirby DM, Rennie KJ, Smulders-Srinivasan TK, Acin-Perez R, Whittington M, Enriquez JA et al. Transmitochondrial embryonic stem cells containing pathogenic mtDNA mutations are compromised in neuronal differentiation. Cell Prolif 2009; 42: 413–424.
Tachibana M, Sparman M, Sritanaudomchai H, Ma H, Clepper L, Woodward J et al. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 2009; 461: 367–372.
Facucho-Oliveira JM, St John JC . The relationship between pluripotency and mitochondrial DNA proliferation during early embryo development and embryonic stem cell differentiation. Stem Cell Rev 2009; 5: 140–158.
Sundaresan P, Kumar SM, Thompson S, Fingert JH . Reduced frequency of known mutations in a cohort of LHON patients from India. Ophthalmic Genet 2010; 31: 196–199.
McEachern MJ, Iyer S, Fulton TB, Blackburn EH . Telomere fusions caused by mutating the terminal region of telomeric DNA. Proc Natl Acad Sci USA 2000; 97: 11409–11414.
Acknowledgements
Partial funding for this work has been provided by NIH-1K18DC009121 (Bennett/Rao), NIH- 5P50NS039788 (Bennett), Qimonda Endowment from the VCU School of Engineering (Rao) and Fellowship from the American Parkinson's Disease Association (Iyer). Recombinant MTD–TFAM was obtained by Bennett through an MTA with Gencia Corporation, Charlottesville, VA. LHON cybrid cells were a kind gift from Dr Russell Swederlow.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on Gene Therapy website
Rights and permissions
About this article
Cite this article
Iyer, S., Xiao, E., Alsayegh, K. et al. Mitochondrial gene replacement in human pluripotent stem cell-derived neural progenitors. Gene Ther 19, 469–475 (2012). https://doi.org/10.1038/gt.2011.134
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2011.134
Keywords
This article is cited by
-
Mitochondrial DNA mutation affects the pluripotency of embryonic stem cells with metabolism modulation
Genome Instability & Disease (2022)
-
Silk 3D matrices incorporating human neural progenitor cells for neural tissue engineering applications
Polymer Journal (2015)
-
Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy
European Journal of Human Genetics (2013)
-
The regulation of mitochondrial DNA copy number in glioblastoma cells
Cell Death & Differentiation (2013)